Theranostic MRI liposomes for magnetic targeting and ultrasound triggered release of the antivascular CA4P
- 10 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 322, 137-148
- https://doi.org/10.1016/j.jconrel.2020.03.003
Abstract
No abstract availableFunding Information
- Labex MiChem
- Le Programme Investissements d'Avenir (ANR-11-IDEX-0004-02)
- IDEX Imageries du Vivant of Sorbonne Paris Cité
- CNRS
- Inserm
- Institut Pasteur Weizmann
- France Life Imaging
- Life Imaging Facility of Paris Descartes University
- GDR AIM
- CNRS
- Inserm
- ENSCP ChimieParistech
This publication has 46 references indexed in Scilit:
- Evaluation of Nonradiative Clinical Imaging Techniques for the Longitudinal Assessment of Tumour Growth in Murine CT26 Colon CarcinomaInternational Journal of Molecular Imaging, 2013
- Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatmentsBMC Cancer, 2012
- Cholesterol Superlattice Modulates CA4P Release from Liposomes and CA4P Cytotoxicity on Mammary Cancer CellsBiophysical Journal, 2012
- Synthesis and Structure–Activity Relationships of Constrained Heterocyclic Analogues of Combretastatin A4ChemMedChem, 2011
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting AgentsCancer Treatment Reviews, 2011
- Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- MR-guided transcranial brain HIFU in small animal modelsPhysics in Medicine & Biology, 2009
- Magnetically Triggered Reversible Controlled Drug Delivery from Microfabricated Polymeric Multireservoir DevicesAdvanced Materials, 2009
- Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor EffectClinical Cancer Research, 2007
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989